FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * BADDOUR LINDA 2. Issuer Name and Ticker or Trading Symbol Cryoport, Inc. [ CYRX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350
3. Date of Earliest Transaction (MM/DD/YYYY)
3/15/2021
(Street)
BRENTWOOD, TN 37027
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock  $57.87  3/15/2021    A     6667       (1) 3/15/2028  Common Stock  6667  $0  6667  D   
Option to purchase common stock  $57.87  3/15/2021    A     683       (2) 3/15/2028  Common Stock  683  $0  683  D   
Restricted Stock Rights   (5) 3/15/2021    A     341       (3)  (3) Common Stock  341  $0  341  D   
Restricted Stock Rights   (5) 3/15/2021    A     3333       (4)  (4) Common Stock  3333  $0  3333  D   

Explanation of Responses:
(1)  1/36th of options vest on the 15th of the month for thirty-six months beginning April 15, 2021.
(2)  228 options vest on March 30, 2021. The remaining 455 options vest on April 29, 2021.
(3)  The restricted stock rights vest on April 29, 2021.
(4)  The restricted stock rights vest in three equal annual installments beginning March 15, 2022.
(5)  Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BADDOUR LINDA
C/O CRYOPORT INC.
112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027
X



Signatures
/s/Linda Baddour 3/17/2021
**Signature of Reporting Person Date